MiSaver (umbilical cord blood derived nucleated cells)
/ HONYA Medical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 21, 2025
SEMIAMI: Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II
(clinicaltrials.gov)
- P2 | N=100 | Not yet recruiting | Sponsor: HONYA Medical Co Ltd
New P2 trial • Cardiovascular • Myocardial Infarction
1 to 1
Of
1
Go to page
1